Pertuzumab OverviewPertuzumab (also called 2C4, trade name Perjeta) is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer. Side effects in more than half the people taking it include diarrhea, hair loss, and loss of neutrophils; more than 10% experience loss of red blood cells, hypersensitivity or aller...
Read more Pertuzumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pertuzumab
Recent Pertuzumab Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Vial: 420mg/14ml
Other drugs which contain Pertuzumab or a similar ingredient: (3 results)
- PERJETA Pertuzumab1 discussion
- PERTUZUMAB + TRASTUZUMAB + HYALURONIDASE
- PHESGO Pertuzumab + Trastuzumab + Hyaluronidase-zzxf